nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC15A2—choroid plexus—malignant glioma	0.0653	0.708	CbGeAlD
Valganciclovir—Wound dehiscence—Carmustine—malignant glioma	0.0628	0.0753	CcSEcCtD
Valganciclovir—Pneumocystis jirovecii pneumonia—Temozolomide—malignant glioma	0.0558	0.0668	CcSEcCtD
Valganciclovir—Faecal incontinence—Carmustine—malignant glioma	0.0143	0.0172	CcSEcCtD
Valganciclovir—Faecal incontinence—Temozolomide—malignant glioma	0.0139	0.0166	CcSEcCtD
Valganciclovir—Oral candidiasis—Carmustine—malignant glioma	0.0114	0.0137	CcSEcCtD
Valganciclovir—Oral candidiasis—Temozolomide—malignant glioma	0.011	0.0132	CcSEcCtD
Valganciclovir—Rigors—Temozolomide—malignant glioma	0.00857	0.0103	CcSEcCtD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.00798	0.109	CbGpPWpGaD
Valganciclovir—Thinking abnormal—Carmustine—malignant glioma	0.00791	0.00948	CcSEcCtD
Valganciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.00782	0.107	CbGpPWpGaD
Valganciclovir—Viral infection—Temozolomide—malignant glioma	0.00775	0.00928	CcSEcCtD
Valganciclovir—Leukocytosis—Carmustine—malignant glioma	0.0077	0.00923	CcSEcCtD
Valganciclovir—Musculoskeletal pain—Temozolomide—malignant glioma	0.00708	0.00848	CcSEcCtD
Valganciclovir—Candida infection—Carmustine—malignant glioma	0.00691	0.00828	CcSEcCtD
Valganciclovir—Influenza like illness—Temozolomide—malignant glioma	0.00679	0.00814	CcSEcCtD
Valganciclovir—Candida infection—Temozolomide—malignant glioma	0.00668	0.008	CcSEcCtD
Valganciclovir—Coma—Carmustine—malignant glioma	0.00662	0.00793	CcSEcCtD
Valganciclovir—Aplastic anaemia—Temozolomide—malignant glioma	0.00657	0.00787	CcSEcCtD
Valganciclovir—Neoplasm—Carmustine—malignant glioma	0.00655	0.00784	CcSEcCtD
Valganciclovir—Neoplasm—Temozolomide—malignant glioma	0.00633	0.00758	CcSEcCtD
Valganciclovir—Abnormal vision—Carmustine—malignant glioma	0.00631	0.00757	CcSEcCtD
Valganciclovir—Sepsis—Carmustine—malignant glioma	0.00628	0.00753	CcSEcCtD
Valganciclovir—Mental disability—Carmustine—malignant glioma	0.00628	0.00753	CcSEcCtD
Valganciclovir—Abnormal vision—Temozolomide—malignant glioma	0.0061	0.00731	CcSEcCtD
Valganciclovir—Phlebitis—Carmustine—malignant glioma	0.0061	0.00731	CcSEcCtD
Valganciclovir—Mental disability—Temozolomide—malignant glioma	0.00607	0.00727	CcSEcCtD
Valganciclovir—Thrombophlebitis—Carmustine—malignant glioma	0.00607	0.00727	CcSEcCtD
Valganciclovir—Diabetes mellitus—Carmustine—malignant glioma	0.00604	0.00724	CcSEcCtD
Valganciclovir—Ear pain—Temozolomide—malignant glioma	0.00595	0.00713	CcSEcCtD
Valganciclovir—Thrombophlebitis—Temozolomide—malignant glioma	0.00587	0.00703	CcSEcCtD
Valganciclovir—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00584	0.007	CcSEcCtD
Valganciclovir—Eye pain—Carmustine—malignant glioma	0.00582	0.00697	CcSEcCtD
Valganciclovir—Deafness—Temozolomide—malignant glioma	0.00568	0.0068	CcSEcCtD
Valganciclovir—Eye pain—Temozolomide—malignant glioma	0.00563	0.00674	CcSEcCtD
Valganciclovir—Amnesia—Carmustine—malignant glioma	0.00559	0.0067	CcSEcCtD
Valganciclovir—Nasal congestion—Temozolomide—malignant glioma	0.00558	0.00668	CcSEcCtD
Valganciclovir—SLC6A14—Amine compound SLC transporters—SLC6A3—malignant glioma	0.00542	0.0742	CbGpPWpGaD
Valganciclovir—Amnesia—Temozolomide—malignant glioma	0.00541	0.00648	CcSEcCtD
Valganciclovir—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00538	0.00645	CcSEcCtD
Valganciclovir—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00526	0.0063	CcSEcCtD
Valganciclovir—SLC15A2—retina—malignant glioma	0.00499	0.0541	CbGeAlD
Valganciclovir—Ataxia—Carmustine—malignant glioma	0.00494	0.00592	CcSEcCtD
Valganciclovir—Hypokalaemia—Carmustine—malignant glioma	0.00478	0.00573	CcSEcCtD
Valganciclovir—Ataxia—Temozolomide—malignant glioma	0.00478	0.00572	CcSEcCtD
Valganciclovir—Dehydration—Temozolomide—malignant glioma	0.00472	0.00566	CcSEcCtD
Valganciclovir—Dry skin—Temozolomide—malignant glioma	0.00466	0.00558	CcSEcCtD
Valganciclovir—Hypokalaemia—Temozolomide—malignant glioma	0.00462	0.00554	CcSEcCtD
Valganciclovir—SLC15A2—telencephalon—malignant glioma	0.00459	0.0498	CbGeAlD
Valganciclovir—Dysphagia—Carmustine—malignant glioma	0.00454	0.00544	CcSEcCtD
Valganciclovir—Abdominal distension—Temozolomide—malignant glioma	0.00442	0.00529	CcSEcCtD
Valganciclovir—Dysphagia—Temozolomide—malignant glioma	0.00439	0.00526	CcSEcCtD
Valganciclovir—Pancytopenia—Carmustine—malignant glioma	0.00431	0.00517	CcSEcCtD
Valganciclovir—Sweating increased—Temozolomide—malignant glioma	0.00428	0.00512	CcSEcCtD
Valganciclovir—Neutropenia—Carmustine—malignant glioma	0.00425	0.00509	CcSEcCtD
Valganciclovir—Bronchitis—Temozolomide—malignant glioma	0.00422	0.00506	CcSEcCtD
Valganciclovir—Pancytopenia—Temozolomide—malignant glioma	0.00417	0.00499	CcSEcCtD
Valganciclovir—Dysuria—Temozolomide—malignant glioma	0.0041	0.00492	CcSEcCtD
Valganciclovir—Neutropenia—Temozolomide—malignant glioma	0.0041	0.00492	CcSEcCtD
Valganciclovir—Hyperglycaemia—Carmustine—malignant glioma	0.0041	0.00491	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00408	0.00489	CcSEcCtD
Valganciclovir—Pneumonia—Carmustine—malignant glioma	0.00407	0.00488	CcSEcCtD
Valganciclovir—Pollakiuria—Temozolomide—malignant glioma	0.00406	0.00486	CcSEcCtD
Valganciclovir—Erectile dysfunction—Temozolomide—malignant glioma	0.00404	0.00484	CcSEcCtD
Valganciclovir—Depression—Carmustine—malignant glioma	0.00404	0.00484	CcSEcCtD
Valganciclovir—SLC6A14—NRF2 pathway—FTH1—malignant glioma	0.00402	0.055	CbGpPWpGaD
Valganciclovir—Photosensitivity reaction—Temozolomide—malignant glioma	0.00401	0.0048	CcSEcCtD
Valganciclovir—Renal failure—Carmustine—malignant glioma	0.00398	0.00477	CcSEcCtD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.00398	0.0545	CbGpPWpGaD
Valganciclovir—Weight decreased—Temozolomide—malignant glioma	0.00397	0.00476	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Carmustine—malignant glioma	0.00397	0.00476	CcSEcCtD
Valganciclovir—Hyperglycaemia—Temozolomide—malignant glioma	0.00396	0.00474	CcSEcCtD
Valganciclovir—Stomatitis—Carmustine—malignant glioma	0.00395	0.00473	CcSEcCtD
Valganciclovir—Urinary tract infection—Carmustine—malignant glioma	0.00394	0.00472	CcSEcCtD
Valganciclovir—Pneumonia—Temozolomide—malignant glioma	0.00394	0.00472	CcSEcCtD
Valganciclovir—Infestation NOS—Temozolomide—malignant glioma	0.00391	0.00469	CcSEcCtD
Valganciclovir—Infestation—Temozolomide—malignant glioma	0.00391	0.00469	CcSEcCtD
Valganciclovir—Depression—Temozolomide—malignant glioma	0.0039	0.00468	CcSEcCtD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00385	0.0527	CbGpPWpGaD
Valganciclovir—Neuropathy peripheral—Temozolomide—malignant glioma	0.00384	0.0046	CcSEcCtD
Valganciclovir—Stomatitis—Temozolomide—malignant glioma	0.00382	0.00457	CcSEcCtD
Valganciclovir—Urinary tract infection—Temozolomide—malignant glioma	0.0038	0.00456	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Temozolomide—malignant glioma	0.0037	0.00443	CcSEcCtD
Valganciclovir—Sinusitis—Temozolomide—malignant glioma	0.00367	0.0044	CcSEcCtD
Valganciclovir—Haemoglobin—Carmustine—malignant glioma	0.00365	0.00438	CcSEcCtD
Valganciclovir—Haemorrhage—Carmustine—malignant glioma	0.00364	0.00436	CcSEcCtD
Valganciclovir—Hallucination—Carmustine—malignant glioma	0.00362	0.00433	CcSEcCtD
Valganciclovir—SLC15A2—medulla oblongata—malignant glioma	0.00361	0.0391	CbGeAlD
Valganciclovir—Oedema peripheral—Carmustine—malignant glioma	0.00358	0.00429	CcSEcCtD
Valganciclovir—Connective tissue disorder—Carmustine—malignant glioma	0.00357	0.00428	CcSEcCtD
Valganciclovir—Haemoglobin—Temozolomide—malignant glioma	0.00353	0.00423	CcSEcCtD
Valganciclovir—Haemorrhage—Temozolomide—malignant glioma	0.00351	0.00421	CcSEcCtD
Valganciclovir—Hepatitis—Temozolomide—malignant glioma	0.00351	0.00421	CcSEcCtD
Valganciclovir—Visual impairment—Carmustine—malignant glioma	0.0035	0.0042	CcSEcCtD
Valganciclovir—Hallucination—Temozolomide—malignant glioma	0.0035	0.00419	CcSEcCtD
Valganciclovir—Pharyngitis—Temozolomide—malignant glioma	0.00349	0.00418	CcSEcCtD
Valganciclovir—Urinary tract disorder—Temozolomide—malignant glioma	0.00347	0.00416	CcSEcCtD
Valganciclovir—Oedema peripheral—Temozolomide—malignant glioma	0.00346	0.00415	CcSEcCtD
Valganciclovir—Connective tissue disorder—Temozolomide—malignant glioma	0.00345	0.00414	CcSEcCtD
Valganciclovir—Urethral disorder—Temozolomide—malignant glioma	0.00344	0.00413	CcSEcCtD
Valganciclovir—Eye disorder—Carmustine—malignant glioma	0.0034	0.00407	CcSEcCtD
Valganciclovir—Visual impairment—Temozolomide—malignant glioma	0.00339	0.00406	CcSEcCtD
Valganciclovir—SLC15A2—midbrain—malignant glioma	0.0033	0.0358	CbGeAlD
Valganciclovir—Eye disorder—Temozolomide—malignant glioma	0.00328	0.00393	CcSEcCtD
Valganciclovir—Tinnitus—Temozolomide—malignant glioma	0.00328	0.00392	CcSEcCtD
Valganciclovir—Cardiac disorder—Temozolomide—malignant glioma	0.00326	0.00391	CcSEcCtD
Valganciclovir—Arrhythmia—Carmustine—malignant glioma	0.00325	0.00389	CcSEcCtD
Valganciclovir—SLC15A2—spinal cord—malignant glioma	0.00322	0.0349	CbGeAlD
Valganciclovir—Alopecia—Carmustine—malignant glioma	0.00321	0.00385	CcSEcCtD
Valganciclovir—Angiopathy—Temozolomide—malignant glioma	0.00319	0.00382	CcSEcCtD
Valganciclovir—Mental disorder—Carmustine—malignant glioma	0.00319	0.00382	CcSEcCtD
Valganciclovir—Immune system disorder—Temozolomide—malignant glioma	0.00317	0.0038	CcSEcCtD
Valganciclovir—Mediastinal disorder—Temozolomide—malignant glioma	0.00317	0.00379	CcSEcCtD
Valganciclovir—Malnutrition—Carmustine—malignant glioma	0.00317	0.00379	CcSEcCtD
Valganciclovir—Chills—Temozolomide—malignant glioma	0.00315	0.00378	CcSEcCtD
Valganciclovir—Alopecia—Temozolomide—malignant glioma	0.0031	0.00372	CcSEcCtD
Valganciclovir—Mental disorder—Temozolomide—malignant glioma	0.00308	0.00369	CcSEcCtD
Valganciclovir—Back pain—Carmustine—malignant glioma	0.00306	0.00367	CcSEcCtD
Valganciclovir—Malnutrition—Temozolomide—malignant glioma	0.00306	0.00366	CcSEcCtD
Valganciclovir—Dysgeusia—Temozolomide—malignant glioma	0.003	0.00359	CcSEcCtD
Valganciclovir—Vision blurred—Carmustine—malignant glioma	0.00298	0.00357	CcSEcCtD
Valganciclovir—Tremor—Carmustine—malignant glioma	0.00297	0.00355	CcSEcCtD
Valganciclovir—Back pain—Temozolomide—malignant glioma	0.00296	0.00354	CcSEcCtD
Valganciclovir—Anaemia—Carmustine—malignant glioma	0.00293	0.0035	CcSEcCtD
Valganciclovir—Agitation—Carmustine—malignant glioma	0.00291	0.00348	CcSEcCtD
Valganciclovir—Vision blurred—Temozolomide—malignant glioma	0.00288	0.00345	CcSEcCtD
Valganciclovir—Tremor—Temozolomide—malignant glioma	0.00287	0.00343	CcSEcCtD
Valganciclovir—Ill-defined disorder—Temozolomide—malignant glioma	0.00284	0.0034	CcSEcCtD
Valganciclovir—Leukopenia—Carmustine—malignant glioma	0.00283	0.00339	CcSEcCtD
Valganciclovir—Anaemia—Temozolomide—malignant glioma	0.00283	0.00339	CcSEcCtD
Valganciclovir—Agitation—Temozolomide—malignant glioma	0.00281	0.00337	CcSEcCtD
Valganciclovir—Malaise—Temozolomide—malignant glioma	0.00276	0.0033	CcSEcCtD
Valganciclovir—Vertigo—Temozolomide—malignant glioma	0.00275	0.00329	CcSEcCtD
Valganciclovir—Convulsion—Carmustine—malignant glioma	0.00274	0.00329	CcSEcCtD
Valganciclovir—Leukopenia—Temozolomide—malignant glioma	0.00274	0.00328	CcSEcCtD
Valganciclovir—Hypertension—Carmustine—malignant glioma	0.00273	0.00327	CcSEcCtD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.00273	0.0373	CbGpPWpGaD
Valganciclovir—Anxiety—Carmustine—malignant glioma	0.00269	0.00322	CcSEcCtD
Valganciclovir—Cough—Temozolomide—malignant glioma	0.00267	0.0032	CcSEcCtD
Valganciclovir—Convulsion—Temozolomide—malignant glioma	0.00265	0.00318	CcSEcCtD
Valganciclovir—Hypertension—Temozolomide—malignant glioma	0.00264	0.00316	CcSEcCtD
Valganciclovir—SLC15A2—central nervous system—malignant glioma	0.00261	0.0283	CbGeAlD
Valganciclovir—Confusional state—Carmustine—malignant glioma	0.0026	0.00312	CcSEcCtD
Valganciclovir—Arthralgia—Temozolomide—malignant glioma	0.0026	0.00312	CcSEcCtD
Valganciclovir—Anxiety—Temozolomide—malignant glioma	0.00259	0.00311	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00259	0.0031	CcSEcCtD
Valganciclovir—Oedema—Carmustine—malignant glioma	0.00258	0.00309	CcSEcCtD
Valganciclovir—Discomfort—Temozolomide—malignant glioma	0.00257	0.00308	CcSEcCtD
Valganciclovir—Infection—Carmustine—malignant glioma	0.00257	0.00307	CcSEcCtD
Valganciclovir—SLC15A2—cerebellum—malignant glioma	0.00255	0.0277	CbGeAlD
Valganciclovir—Dry mouth—Temozolomide—malignant glioma	0.00255	0.00305	CcSEcCtD
Valganciclovir—Thrombocytopenia—Carmustine—malignant glioma	0.00253	0.00303	CcSEcCtD
Valganciclovir—Tachycardia—Carmustine—malignant glioma	0.00252	0.00302	CcSEcCtD
Valganciclovir—Confusional state—Temozolomide—malignant glioma	0.00252	0.00302	CcSEcCtD
Valganciclovir—Oedema—Temozolomide—malignant glioma	0.0025	0.00299	CcSEcCtD
Valganciclovir—Anaphylactic shock—Temozolomide—malignant glioma	0.0025	0.00299	CcSEcCtD
Valganciclovir—Infection—Temozolomide—malignant glioma	0.00248	0.00297	CcSEcCtD
Valganciclovir—Anorexia—Carmustine—malignant glioma	0.00246	0.00295	CcSEcCtD
Valganciclovir—Nervous system disorder—Temozolomide—malignant glioma	0.00245	0.00293	CcSEcCtD
Valganciclovir—Thrombocytopenia—Temozolomide—malignant glioma	0.00244	0.00293	CcSEcCtD
Valganciclovir—Skin disorder—Temozolomide—malignant glioma	0.00242	0.00291	CcSEcCtD
Valganciclovir—Hypotension—Carmustine—malignant glioma	0.00241	0.00289	CcSEcCtD
Valganciclovir—Hyperhidrosis—Temozolomide—malignant glioma	0.00241	0.00289	CcSEcCtD
Valganciclovir—Anorexia—Temozolomide—malignant glioma	0.00238	0.00285	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00235	0.00282	CcSEcCtD
Valganciclovir—Insomnia—Carmustine—malignant glioma	0.00234	0.0028	CcSEcCtD
Valganciclovir—Paraesthesia—Carmustine—malignant glioma	0.00232	0.00278	CcSEcCtD
Valganciclovir—Dyspnoea—Carmustine—malignant glioma	0.0023	0.00276	CcSEcCtD
Valganciclovir—Somnolence—Carmustine—malignant glioma	0.0023	0.00275	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00227	0.00272	CcSEcCtD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00227	0.031	CbGpPWpGaD
Valganciclovir—Insomnia—Temozolomide—malignant glioma	0.00226	0.00271	CcSEcCtD
Valganciclovir—Decreased appetite—Carmustine—malignant glioma	0.00225	0.00269	CcSEcCtD
Valganciclovir—Paraesthesia—Temozolomide—malignant glioma	0.00224	0.00269	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00223	0.00267	CcSEcCtD
Valganciclovir—Dyspnoea—Temozolomide—malignant glioma	0.00223	0.00267	CcSEcCtD
Valganciclovir—Somnolence—Temozolomide—malignant glioma	0.00222	0.00266	CcSEcCtD
Valganciclovir—Pain—Carmustine—malignant glioma	0.00221	0.00265	CcSEcCtD
Valganciclovir—Constipation—Carmustine—malignant glioma	0.00221	0.00265	CcSEcCtD
Valganciclovir—Dyspepsia—Temozolomide—malignant glioma	0.0022	0.00263	CcSEcCtD
Valganciclovir—Decreased appetite—Temozolomide—malignant glioma	0.00217	0.0026	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00216	0.00258	CcSEcCtD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00215	0.0295	CbGpPWpGaD
Valganciclovir—Fatigue—Temozolomide—malignant glioma	0.00215	0.00258	CcSEcCtD
Valganciclovir—Pain—Temozolomide—malignant glioma	0.00213	0.00256	CcSEcCtD
Valganciclovir—Constipation—Temozolomide—malignant glioma	0.00213	0.00256	CcSEcCtD
Valganciclovir—Feeling abnormal—Carmustine—malignant glioma	0.00213	0.00255	CcSEcCtD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00212	0.029	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Carmustine—malignant glioma	0.00211	0.00253	CcSEcCtD
Valganciclovir—SLC15A2—brain—malignant glioma	0.00207	0.0225	CbGeAlD
Valganciclovir—Feeling abnormal—Temozolomide—malignant glioma	0.00206	0.00246	CcSEcCtD
Valganciclovir—Abdominal pain—Carmustine—malignant glioma	0.00204	0.00245	CcSEcCtD
Valganciclovir—Body temperature increased—Carmustine—malignant glioma	0.00204	0.00245	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Temozolomide—malignant glioma	0.00204	0.00245	CcSEcCtD
Valganciclovir—Urticaria—Temozolomide—malignant glioma	0.00198	0.00238	CcSEcCtD
Valganciclovir—Abdominal pain—Temozolomide—malignant glioma	0.00197	0.00236	CcSEcCtD
Valganciclovir—Body temperature increased—Temozolomide—malignant glioma	0.00197	0.00236	CcSEcCtD
Valganciclovir—Hypersensitivity—Carmustine—malignant glioma	0.0019	0.00228	CcSEcCtD
Valganciclovir—Asthenia—Carmustine—malignant glioma	0.00185	0.00222	CcSEcCtD
Valganciclovir—Hypersensitivity—Temozolomide—malignant glioma	0.00184	0.0022	CcSEcCtD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00182	0.0249	CbGpPWpGaD
Valganciclovir—Asthenia—Temozolomide—malignant glioma	0.00179	0.00215	CcSEcCtD
Valganciclovir—Diarrhoea—Carmustine—malignant glioma	0.00177	0.00212	CcSEcCtD
Valganciclovir—Pruritus—Temozolomide—malignant glioma	0.00177	0.00212	CcSEcCtD
Valganciclovir—Dizziness—Carmustine—malignant glioma	0.00171	0.00205	CcSEcCtD
Valganciclovir—Diarrhoea—Temozolomide—malignant glioma	0.00171	0.00205	CcSEcCtD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00169	0.0231	CbGpPWpGaD
Valganciclovir—Dizziness—Temozolomide—malignant glioma	0.00165	0.00198	CcSEcCtD
Valganciclovir—Vomiting—Carmustine—malignant glioma	0.00164	0.00197	CcSEcCtD
Valganciclovir—Dermatitis—Carmustine—malignant glioma	0.00163	0.00195	CcSEcCtD
Valganciclovir—Headache—Carmustine—malignant glioma	0.00162	0.00194	CcSEcCtD
Valganciclovir—SLC6A14—NRF2 pathway—SLC5A5—malignant glioma	0.00161	0.022	CbGpPWpGaD
Valganciclovir—Vomiting—Temozolomide—malignant glioma	0.00159	0.0019	CcSEcCtD
Valganciclovir—Dermatitis—Temozolomide—malignant glioma	0.00157	0.00188	CcSEcCtD
Valganciclovir—Headache—Temozolomide—malignant glioma	0.00156	0.00187	CcSEcCtD
Valganciclovir—Nausea—Carmustine—malignant glioma	0.00153	0.00184	CcSEcCtD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A3—malignant glioma	0.00153	0.0209	CbGpPWpGaD
Valganciclovir—Nausea—Temozolomide—malignant glioma	0.00148	0.00178	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00141	0.0193	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTP1—malignant glioma	0.00129	0.0177	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00129	0.0176	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.00116	0.0159	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00113	0.0154	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOD—malignant glioma	0.00109	0.015	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00107	0.0147	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—PDGFB—malignant glioma	0.00102	0.014	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00102	0.0139	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00101	0.0139	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.000995	0.0136	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000964	0.0132	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000946	0.0129	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000666	0.00911	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000618	0.00845	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000609	0.00833	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000565	0.00773	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00056	0.00767	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000532	0.00728	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000518	0.00708	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000515	0.00704	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000494	0.00676	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00049	0.0067	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000481	0.00657	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000479	0.00655	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000456	0.00624	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000445	0.00608	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000423	0.00579	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000265	0.00363	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000246	0.00337	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000243	0.00333	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000232	0.00317	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000226	0.00309	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000222	0.00304	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000215	0.00294	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000105	0.00144	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.75e-05	0.00133	CbGpPWpGaD
